| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/12/2001 | WO2001049270A2 Odor-masking coating for a pharmaceutical preparation |
| 07/12/2001 | WO2001049269A1 Sustained-releasing anthelmintic compositions comprising praziquantel |
| 07/12/2001 | WO2001049268A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | WO2001049267A1 Multi-tablet oxybutynin system for treating incontinence |
| 07/12/2001 | WO2001049266A2 Iron chelator delivery system |
| 07/12/2001 | WO2001049265A1 Proteoliposomes containing an integral membrane protein having one or more transmembrane domains |
| 07/12/2001 | WO2001049264A2 Pharmaceutical compositions for oral administration |
| 07/12/2001 | WO2001049263A1 Inhalation particles |
| 07/12/2001 | WO2001049262A1 Fenofibrate galenic formulations and method for obtaining same |
| 07/12/2001 | WO2001049261A2 Stable aqueous deoxyfructosazine solution |
| 07/12/2001 | WO2001049260A2 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | WO2001049256A2 Oil-free cosmetic or dermatological preparations containing solid and liquid uv filter substances |
| 07/12/2001 | WO2001049252A2 Oil-in-water type cosmetic or dermatological preparations |
| 07/12/2001 | WO2001049249A2 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/12/2001 | WO2001049246A2 Sustained release tablet formulations comprising clarithromycin |
| 07/12/2001 | WO2001049124A1 Release of lipophilic active agents from chewing gum |
| 07/12/2001 | WO2001044485A8 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 07/12/2001 | WO2001003669A3 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 07/12/2001 | WO2001001956A3 Solid preparations containing paroxetine |
| 07/12/2001 | WO2000078697A3 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000066087A9 Emulsion-based processes for making microparticles |
| 07/12/2001 | WO2000041528A9 Improved controlled release compositions and method |
| 07/12/2001 | WO1999066031A3 Pharmaceutical factor vii preparation |
| 07/12/2001 | US20010007866 Treatment of pruritus with vitamin d and analogs thereof |
| 07/12/2001 | US20010007863 Drugs; metabolism diseases; osteoporosis |
| 07/12/2001 | US20010007861 Applying vibrational energy to cells |
| 07/12/2001 | US20010007853 By inhalation |
| 07/12/2001 | US20010007771 Cationic polymers and lipids for the delivery of nucleic acids |
| 07/12/2001 | US20010007758 Administering mixture of synthetic polypeptides |
| 07/12/2001 | US20010007681 Diltiazem controlled release formulation and method of manufacture |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007678 Melt extrusion mixture containing itraconazole |
| 07/12/2001 | US20010007675 Cosmetic and dermatological compositions containing aminoalchohol derivatives containing a urea functional group and uses thereof |
| 07/12/2001 | US20010007673 Sustained-release delayed gels |
| 07/12/2001 | US20010007671 Cosmetic, pharmaceutical, or dermatological patch |
| 07/12/2001 | US20010007670 Novel formulations comprising lipid-regulating agents |
| 07/12/2001 | US20010007669 Antilipemic agent |
| 07/12/2001 | US20010007668 Solvent system for enhancing solubility |
| 07/12/2001 | US20010007667 Liposome-encapsulated poly iclc |
| 07/12/2001 | US20010007666 Destroying endosomal membrane in response to low pH |
| 07/12/2001 | US20010007665 Respiratory system |
| 07/12/2001 | US20010007664 Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process |
| 07/12/2001 | US20010007663 Microemulsions for use as vehicles for administration of active compounds |
| 07/12/2001 | US20010007662 Aqueous formulation suitable for lyophilization; biologically active form of nerve growth factor with bulking agent, buffer and water |
| 07/12/2001 | US20010007658 Medium and matrix for long-term proliferation of cells |
| 07/12/2001 | US20010007651 Masking and eliminating odors; preservative, counterirritant, solubility enhancer, antiseptic, fungicide, microbiocide, anti-infective, healing agent; smoker's-breath; placebo |
| 07/12/2001 | DE19964085A1 Particulate solid drug carrier, providing retarded release and high bioavailability, comprising lipid-drug conjugate, e.g. tributyrin as source of cell differentiation inhibitor butyric acid |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE19962427A1 Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung Multifunctional encapsulated biologically active food component, process for their preparation and their use |
| 07/12/2001 | DE19961307A1 Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut Medical product for moisturizing and cleansing of the nasal mucosa |
| 07/12/2001 | DE19960154A1 Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie Flat pharmaceutical preparation for transmucosal administration of oxycodone or a similar drug in the oral cavity, for use in the treatment of pain and addiction treatment |
| 07/12/2001 | DE19952586A1 Mikrokapselsystem zur umweltinduzierten Abgabe von Wirkstoffen Microcapsule system for environmentally induced release of active substances |
| 07/12/2001 | DE19952073A1 Verfahren zur Herstellung von nanopartikulären Chitosanen oder Chitosan-Derivaten Process for preparing nanoparticulate chitosans or chitosan derivatives |
| 07/12/2001 | DE10054713A1 Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung Transdermal therapeutic systems with improved stability and a method for their preparation |
| 07/12/2001 | DE10001683A1 Preparation comprising separate carrier material and solvent for the formation of an implant by admixture shortly before use |
| 07/12/2001 | DE10001682A1 Preparation comprising separate carrier material and solvent for the formation of particles or implants by admixture shortly before use and dispersion in an outer phase |
| 07/12/2001 | DE10000648A1 New crosslinked copolymers containing vinyl lactam and N-(sulfoalkyl)-acrylamide salt repeating units, especially useful as thickeners in cosmetic or pharmaceutical compositions |
| 07/12/2001 | DE10000211A1 Ölfreie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an festen und flüssigen UV-Filtersubstanzen Oil-free cosmetic or dermatological compositions containing solid and liquid UV filter substances |
| 07/12/2001 | DE10000210A1 Stable oil-in-water preparations which include a citrate ester, are useful, e.g., in care of skin and are stabilized by a very low density difference between the oil and aqueous phases |
| 07/12/2001 | CA2733819A1 Iron chelator delivery system |
| 07/12/2001 | CA2396379A1 Pharmaceutical compositions for oral administration |
| 07/12/2001 | CA2396037A1 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/12/2001 | CA2395966A1 Multi-tablet oxybutynin system for treating incontinence |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395887A1 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | CA2395803A1 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | CA2395695A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | CA2395132A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | CA2393942A1 Odor-masking coating for a pharmaceutical preparation |
| 07/11/2001 | EP1114646A2 System and method for providing a sterile medical solution containing glucose or glucose-like compounds |
| 07/11/2001 | EP1114645A2 System and method for providing a sterile medical solution containing glucose or glucose-like compounds |
| 07/11/2001 | EP1114644A1 Composition comprising NPH insulin (neutral protamine hagedorn insulin) |
| 07/11/2001 | EP1114643A2 Herb containing ointment for the therapy of dermatologic diseases |
| 07/11/2001 | EP1114641A2 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 07/11/2001 | EP1114144A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113803A1 Antiviral combinations comprising lamivudine and abacavir |
| 07/11/2001 | EP1113799A1 Protein formulations |
| 07/11/2001 | EP1113798A1 Topical formulation of alkyl-, phenyl-pyridone |
| 07/11/2001 | EP1113788A2 Transdermal devices comprising essential oils for aromatherapy |
| 07/11/2001 | EP1113787A1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same |
| 07/11/2001 | EP1113786A1 New pharmaceutical formulation |
| 07/11/2001 | EP1113785A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 07/11/2001 | EP0927037B1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/11/2001 | EP0858328A4 Stable compositions containing n-propargyl-1-aminoindan |
| 07/11/2001 | EP0851734B1 Capsules containing freeze-dried powdered green tea leaves |
| 07/11/2001 | EP0831774B1 Oral dosage and method for treating painful conditions of the oral cavity |
| 07/11/2001 | EP0799615B1 Liposome eye drops |
| 07/11/2001 | EP0758231B1 Taxane class derivative based pharmaceutical compositions |
| 07/11/2001 | EP0754034B1 Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules |
| 07/11/2001 | EP0752847B1 Ophthalmic composition with decreased viscosity |
| 07/11/2001 | EP0746311B1 Medicinal patches for percutaneous administration |
| 07/11/2001 | EP0735876B1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin |
| 07/11/2001 | CN1303296A Process of powder for bath from natural plants |
| 07/11/2001 | CN1303293A Process for producing composite preparation containing nucleic acid |
| 07/11/2001 | CN1303291A Sustained-release composition containing cefaclor |